Allergan, Inc. (AGN) · page 97 of 110
The slide uses a pro-forma bridge to justify the acquisition price and expected returns.
Activist deck · valuation_table · show_valuation_bridge · dense density
Slide locked Sign in to view
Slide schematic 6/6
callout 3/3 disclaimer 1/1 table 1/1 title 1/1
Components 6
primary primary primary disclaimer valuation headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.